Hedge Fund - RA Capital Management

RA Capital Management, based in Boston, is an American investment firm specializing in public and private investments within the healthcare and biotechnology sectors.

Mr. Peter Kolchinsky is a biotechnology investor and scientist who co-founded and leads the Boston-based investment firm RA Capital Management. He is an advocate for biomedical entrepreneurship, writing and teaching about its potential to transform global health. Additionally, he serves on the boards of several public and private drug development companies and has been a member of the Board on Global Science and Technology for the National Academies of Sciences. He graduated from Harvard with a Ph.D. in virology in 2001. After graduation, he received $4 million from Vertex Pharmaceuticals co-founder Rich Aldrich and began selecting biotech stocks at RA Capital. In 2002, he broke even despite the S&P 500 index losing 22%. By the end of 2003, the initial $4 million investment had grown to $13 million.

RA Capital Management manages discretionary assets totaling $11,323,065,361, as reported in their Form ADV dated March 2024. The firm serves 10 clients and, in its most recent 13F filing for Q1 2024, reported managing $7,860,142,471 in 13F securities. The top 10 holdings constitute 51.1% of the portfolio, with the largest holding being 10,108,400 shares of Ascendis Pharma A/S ADR.